FindTrial
Sign In

To determine Whether the presence of Intraperitoneal free Cancer cells in the peritoneum at the time of surgery in operable colorectal Cancers Influences the Recurrence Rates and Survival Rates.

PERITONEAL CYTOLOGY IN OPERABLE COLORECTAL CANCERS A PROSPECTIVE STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/01/006489
Enrollment
301
Registered
2016-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- colorectal cancer Health Condition 2: C18- Malignant neoplasm of colon Health Condition 3: C20- Malignant neoplasm of rectum

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age > 18years All surgically treated colorectal patients

Exclusion criteria

Exclusion criteria: All patients with distant metatstases. All inoperable patients All patients with R+ resections. Patients with pre-operative tumor perforation. Patients with ascites/ peritoneal disease.

Design outcomes

Primary

MeasureTime frame
To determine the one year local, peritoneal and distant recurrence ratesTimepoint: 24 months—

Secondary

MeasureTime frame
To evaluate any difference in cytology yield in pre resection as compared to post resection cytology samples.Timepoint: 24 months—

Countries

India

Contacts

Public ContactAvanish Parmesh Saklani

Tata Memorial Hospital

asaklani@hotmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026